Valproic acid and risk of acute pancreatitis: A population-based case-control study

American Journal of Therapeutics

Volumn 13, Issue 2, 2006, Pages 113-117

  Nørgaard, Mette ^a,b,e   Jacobsen, Jacob ^a   Ratanajamit, Chaveewan ^a,c   Jepsen, Peter ^a   McLaughlin, Joseph K ^b,d   Pedersen, Lars ^a   Sørensen, Henrik Toft ^a,b  

^a AARHUS UNIVERSITY   (Denmark)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

^c PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^d INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^e Department of Clinical Epidemiology ^*  (Denmark)

Author keywords

Acute pancreatitis; Antiepileptics; Case control study; Epidemiology; Valproic acid

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ACUTE PANCREATITIS; ADULT; ANTICONVULSANT THERAPY; ARTICLE; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; DENMARK; DRUG USE; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RISK; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; ACUTE HEMORRHAGIC PANCREATITIS; ADOLESCENT; AGED; CHEMICALLY INDUCED DISORDER; MIDDLE AGED; POPULATION; RISK; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; CASE-CONTROL STUDIES; DENMARK; FEMALE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PANCREATITIS, ACUTE NECROTIZING; POPULATION; RISK FACTORS; VALPROIC ACID;

EID: 33646556391     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-200603000-00005     Document Type: Article

References (25)

1. Perucca E. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS Drugs. 2002;16:695-714.
2. Spina E, Perugi G. Antiepileptic drugs: indications other than epilepsy. Epileptic Disord. 2004;6:57-75.
3. Post RM, Ketter TA, Denicoff K, et al. The place of anticonvulsant therapy in bipolar illness. Psychopharmacology (Berlin). 1996;128:115-129.
4. Batalden PB, Van Dyne BJ, Cloyd J. Pancreatitis associated with valproic acid therapy. Pediatrics. 1979;64:520-522.
5. Coulter DL, Allen RJ. Pancreatitis associated with valproic acid therapy for epilepsy. Ann Neurol. 1980;7:92.
6. Parker PH, Helinek GL, Ghishan FK, et al. Recurrent pancreatitis induced by valproic acid. A case report and review of the literature. Gastroenterology. 1981;80:826-828.
7. Murphy MJ, Lyon IW, Taylor JW, et al. Valproic acid associated pancreatitis in an adult. Lancet. 1981;1:41-42.
8. Williams LH, Reynolds RP, Emery JL. Pancreatitis during sodium valproate treatment. Arch Dis Child. 1983;58:543-544.
9. Wyllie E, Wyllie R, Cruse RP, et al. Pancreatitis associated with valproic acid therapy. Am J Dis Child. 1984;138:912-914.
10. Rosenberg HK, Ortega W. Hemorrhagic pancreatitis in a young child following valproic acid therapy. Clinical and ultrasonic assessment. Clin Pediatr (Philadelphia). 1987;26:98-101.
11. Lott JA, Bond LW, Bobo RC, et al. Valproic acid-associated pancreatitis: report of three cases and a brief review. Clin Chem. 1990;36:395-397.
12. Binek J, Hany A, Heer M. Valproic-acid-induced pancreatitis: case report and review of the literature. J Clin Gastroenterol. 1991;13:690-693.
13. Asconape JJ, Penry JK, Dreifuss FE, et al. Valproate-associated pancreatitis. Epilepsia. 1993;34:177-183.
14. Evans RJ, Miranda RN, Jordan J, et al. Fatal acute pancreatitis caused by valproic acid. Am J Forensic Med Pathol. 1995;16:62-65.
15. Engelmann MDM, Henriksen SD, Tingsgaard LK. Fatal haemorrhagic pancreatitis associated with sodium valproate. Ugeskr Laeg. 1995;157:4357-4358.
16. Fecik SE, Stoner SC, Raphael J, et al. Recurrent acute pancreatitis associated with valproic acid use for mood stabilization. J Clin Psychopharmacol. 1999;19:483-484.
17. Chapman SA, Wacksman GP, Patterson BD. Pancreatitis associated with valproic acid: a review of the literature. Pharmacother. 2001;21:1549-1560.
18. Grauso-Eby NL, Goldfarb O, Feldman-Winter LB, et al. Acute pancreatitis in children from valproic acid: case series and review. Pediatr Neurol. 2003;28:145-148.
19. Wilmink T, Frick TW. Drug-induced pancreatitis. Drug safety. Int J Med Toxicol Drug Exp. 1996;14:406-423.
20. Pellock JM, Wilder BJ, Deaton R, et al. Acute pancreatitis coincident with valproate use: a critical review. Epilepsia. 2002;43:1421-1424.
21. Lancashire RJ, Cheng K, Langman JS. Discrepancies between population-based data and adverse reaction reports in assessing drugs as causes of acute pancreatitis. Aliment Pharmacol Ther. 2003;17:887-893.
22. Szklo M, Nieto FJ. Epidemiology Beyond the Basics. 1st ed. Gaithersburg, MD: Aspen Publishers; 2000.
23. Weinstock MA, Colditz GA, Willett WC, et al. Recall (report) bias and reliability in the retrospective assessment of melanoma risk. Am J Epidemiol. 1991;133:240-245.
24. Floyd A, Pedersen L, Nielsen GL, et al. Secular trends in incidence and 30-day case fatality of acute pancreatitis in North Jutland County, Denmark: a register-based study from 1981-2000. Scand J Gastroenterol. 2002;12:1461-1465.
25. Kobau R, DiIorio CA, Price PH, et al. Prevalence of epilepsy and health status of adults with epilepsy in Georgia and Tennessee: Behavioral Risk Factor Surveillance System, 2002. Epilepsy Behav. 2004;5:358-366.